News

Ophthalmology Times16h
ForSight Robotics completes $125M Series B funding to address global surgeon shortage
ForSight Robotics secures $125M to advance its robotic surgery platform, targeting cataract procedures and additional ...
Ophthalmology Times17h
Breye Therapeutics reports completion of phase 1b for oral NPDR therapy
Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.